A fully integrated clinical information system to support management of end-stage renal disease - Design and implementation

被引:1
|
作者
Mattern, WD
Scott, S
机构
[1] Univ N Carolina, Sch Med, Dialysis Program, Chapel Hill, NC 27514 USA
[2] RMS Dis Management Inc, Informat Syst, McGaw Pk, IL USA
关键词
D O I
10.2165/00115677-200109110-00002
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
End-stage renal disease (ESRD) is relatively rare, but very costly. The ESRD population in the US is elderly, over 40% have diabetes mellitus, and most have additional comorbid conditions. Concerns about the quality and cost of care for people with ESRD in the US prompted the Healthcare Financing Administration (HCFA) to launch a demonstration project to determine whether disease management might improve care at:reduced cost. It also stimulated health plans in the private sector to begin contracting with newly formed ESRD disease management organizations (DMOs). We describe the clinical information system developed by one such organization, RMS Disease Management, an affiliate of Baxter Healthcare Corporation. The system was designed to function within disparate medical care delivery systems and regions, without adding work for providers or health plans. A point-of-care system was implemented using a client server configuration. Data were entered on laptops and uploaded over high-speed lines to a central site. The system was developed over 14 months and implemented in 12 regions in 1998 under a contract with Humana, a national health plan. Highly experienced, locally recruited nephrology nurses co-ordinated care and entered data. The data included standard quality indicators, performance measures and key outcomes, along with data on patient assessment, care management, and comorbid conditions. We have compiled 35 000 months of patient care experience in the past three years, and entered 4000 patients with ESRD into the program, The system has provided comparisons of data at the regional and national levels, an independent reference for auditing claims, rapid turn-around of data to drive outcomes management, and the ability to link all components of care management. The system configuration is scalable and has functioned well across multiple sites of care while maintaining the privacy and security of patient data. Future plans include migration to an internet-based platform, adoption of handheld devices for data entry, and development of an Internet site where patients, their caregivers and their providers can interact. The system is designed to accomodate the evolving scope of disease management for ESRD, broadening to embrace multiple comorbid conditions and increasing its focus on prevention wellness.
引用
收藏
页码:619 / 629
页数:11
相关论文
共 50 条
  • [31] Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update
    Di Cerbo, Alessandro
    Pezzuto, Federica
    Palmieri, Lucia
    Rottigni, Valentina
    Iannitti, Tommaso
    Palmieri, Beniamino
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (06) : 1569 - 1576
  • [32] Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update
    Alessandro Di Cerbo
    Federica Pezzuto
    Lucia Palmieri
    Valentina Rottigni
    Tommaso Iannitti
    Beniamino Palmieri
    [J]. International Urology and Nephrology, 2013, 45 : 1569 - 1576
  • [33] Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease
    Bhatti, Navdeep K.
    Galougahi, Keyvan Karimi
    Paz, Yehuda
    Nazif, Tamim
    Moses, Jeffrey W.
    Leon, Martin B.
    Stone, Gregg W.
    Kirtane, Ajay J.
    Karmpaliotis, Dimitri
    Bokhari, Sabahat
    Hardy, Mark A.
    Dube, Geoffrey
    Mohan, Sumit
    Ratner, Lloyd E.
    Cohen, David J.
    Ali, Ziad A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (08):
  • [34] The management of chronic kidney disease and end-stage renal disease in Nigeria
    Emmanuel I. Agaba
    Antonios H. Tzamaloukas
    [J]. International Urology and Nephrology, 2012, 44 : 653 - 654
  • [35] The management of chronic kidney disease and end-stage renal disease in Nigeria
    Agaba, Emmanuel I.
    Tzamaloukas, Antonios H.
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (02) : 653 - 654
  • [36] Outcomes associated with a disease management program for end-stage renal disease
    Nissenson, AR
    [J]. DISEASE MANAGEMENT & HEALTH OUTCOMES, 2002, 10 (02) : 93 - 100
  • [37] ATTITUDES OF CAREGIVERS TO MANAGEMENT OF END-STAGE RENAL DISEASE IN INFANTS
    Teh, Jun Chuan
    Frieling, Michelle L.
    Sienna, Julianna L.
    Geary, Denis F.
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2011, 31 (04): : 459 - 465
  • [38] Current issues in iron management in end-stage renal disease
    Fishbane, S
    Maesaka, JK
    [J]. SEMINARS IN DIALYSIS, 1997, 10 (01) : 5 - 8
  • [39] Recent developments in the management of infants with end-stage renal disease
    Masataka Honda
    Seiichirou Shishido
    [J]. Clinical and Experimental Nephrology, 1998, 2 (1) : 1 - 11
  • [40] Conservative Management of Patients with End-Stage Renal Disease #408
    Corona, Antonio
    Bigelow, April
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2021, 24 (02) : 287 - 288